Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01879761

Immune Resolution After Staphylococcus Aureus Bacteremia

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
102 (actual)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in patients with and without prior immune dysfunction who survive sepsis from Staphylococcus aureus bacteremia. We hypothesize that patients with prior immune dysfunction will have greater reductions in HLA-DR and other markers of immune function after an episode of sepsis than people who do not have prior immune dysfunction.

Conditions

Timeline

Start date
2013-06-01
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2013-06-18
Last updated
2025-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01879761. Inclusion in this directory is not an endorsement.

Immune Resolution After Staphylococcus Aureus Bacteremia (NCT01879761) · Clinical Trials Directory